They are predicted to act on some anti-tumor targets, such as DNA polymerase kappa, DNA topoisomerase 1, Carbonic anhydrase 7, Glucocorticoid receptor, Lysine N-methyltransferase 6 and Vitamin D3 receptor. Here, POLK is linked to neoplasm.